001444428 000__ 04824cam\a2200589Ia\4500
001444428 001__ 1444428
001444428 003__ OCoLC
001444428 005__ 20230310003709.0
001444428 006__ m\\\\\o\\d\\\\\\\\
001444428 007__ cr\un\nnnunnun
001444428 008__ 220216s2022\\\\sz\\\\\\ob\\\\001\0\eng\d
001444428 019__ $$a1296913864$$a1298394293
001444428 020__ $$a9783030899189$$q(electronic bk.)
001444428 020__ $$a3030899187$$q(electronic bk.)
001444428 020__ $$z3030899179
001444428 020__ $$z9783030899172
001444428 0247_ $$a10.1007/978-3-030-89918-9$$2doi
001444428 035__ $$aSP(OCoLC)1296941655
001444428 040__ $$aYDX$$beng$$cYDX$$dN$T$$dGW5XE$$dEBLCP$$dOCLCO$$dOCLCF$$dBNG$$dSFB$$dUKAHL$$dOCLCQ
001444428 049__ $$aISEA
001444428 050_4 $$aRC271.A62$$bC97 2022
001444428 08204 $$a616.99406$$223
001444428 1001_ $$aCyr, Claude,$$eauthor.
001444428 24510 $$aCannabis and cannabinoid-based medicines in cancer care :$$ba comprehensive guide to medical management /$$cClaude Cyr, Mellar P. Davis, Danial Schecter, Paul Daeninck.
001444428 260__ $$aCham, Switzerland :$$bSpringer,$$c[2022]
001444428 300__ $$a1 online resource
001444428 336__ $$atext$$btxt$$2rdacontent
001444428 337__ $$acomputer$$bc$$2rdamedia
001444428 338__ $$aonline resource$$bcr$$2rdacarrier
001444428 504__ $$aIncludes bibliographical references and index.
001444428 5050_ $$aOverview of the Endocannabinoid System and Endocannabinoidome -- Cannabinoid-Based Medicine: Pharmacology and Drug Interactions -- Future Therapeutic Potential of Synthetic Cannabinoids and Endocannabinoid System Modulators -- Cannabis-Based Medicines as Anti-Cancer Agents -- Cannabinoid-Based Medicines and Cancer Symptom Management -- Patient Evaluation: Precautions and Managing Expectations -- Choosing a Product, Route of Administration, Initial Dosage, Titration, Monitoring and Management of Adverse Effects -- Psychoactive Effects of Cannabinoid-Based Medicines: Exploration and Inquiry.
001444428 506__ $$aAccess limited to authorized users.
001444428 520__ $$aThe use of cannabinoid-based medicines (CBM), and cannabis in particular, has risen steadily among cancer and palliative care patients over the last few years. This textbook aims to address the multiple challenges facing healthcare providers regarding the use of CBM in this vulnerable patient population. It provides insight into the latest preclinical and clinical data and offers a practical approach on the use of CBM in a rapidly evolving landscape. It answers questions regarding the prescribing process and elucidates controversies regarding cannabis disease-modifying effects. The first chapters will review basic concepts of the endocannabinoid system and pharmacology of CBM, while focusing more specifically on the unique characteristics of two main cannabinoids: THC and CBD. Indicating which benefits can be expected from using either or both of these compounds, the book then addresses issues of drug-drug interactions and other challenges involved in prescribing CBM to frail patients with polypharmacy and multiple comorbidities. Comparing available products, both approved and non-approved by the FDA, the book discusses regional challenges for accessing reliably tested and labelled products in the context of standardization efforts. After carefully determining objectives and addressing patient expectations, further chapters will examine the different clinical settings in which CBM may be useful in cancer care and explore symptom management, including cancer pain, anxiety, nausea, and insomnia among others. The possible benefits of cannabis psychoactivity will also be discussed, including harm reduction strategies for patients who wish to explore these effects. Cannabis and Cannabinoid-Based Medicines in Cancer Care: A Comprehensive Guide to Medical Management serves as a comprehensive text for oncologists, palliative care specialists, general practitioners, and nurse practitioners working with cancer patients or in palliative care settings.
001444428 588__ $$aDescription based on print version record.
001444428 650_0 $$aCancer$$xTreatment.
001444428 650_0 $$aCancer$$xAlternative treatment.
001444428 650_0 $$aCannabinoids$$xTherapeutic use.
001444428 650_6 $$aCancer$$xTraitement.
001444428 650_6 $$aCancer$$xMédecines parallèles.
001444428 650_6 $$aCannabinoïdes$$xEmploi en thérapeutique.
001444428 655_0 $$aElectronic books.
001444428 7001_ $$aDavis, Mellar P.,$$eauthor.$$1https://isni.org/isni/0000000116694439
001444428 7001_ $$aSchecter, Danial,$$eauthor.
001444428 7001_ $$aDaeninck, Paul,$$eauthor.
001444428 77608 $$iPrint version:$$z3030899179$$z9783030899172$$w(OCoLC)1269093939
001444428 77608 $$iPrint version:$$aCyr, Claude, author.$$tCannabis and cannabinoid-based medicines in cancer care$$z9783030899172$$w(OCoLC)1295103275
001444428 852__ $$bebk
001444428 85640 $$3Springer Nature$$uhttps://univsouthin.idm.oclc.org/login?url=https://link.springer.com/10.1007/978-3-030-89918-9$$zOnline Access$$91397441.1
001444428 909CO $$ooai:library.usi.edu:1444428$$pGLOBAL_SET
001444428 980__ $$aBIB
001444428 980__ $$aEBOOK
001444428 982__ $$aEbook
001444428 983__ $$aOnline
001444428 994__ $$a92$$bISE